We’re only a few months a way from the end of the year, but pharma companies still have a steady stream of clinical trial results to announce before then. Several companies — including Novo Nordisk (NVO), Viking Therapeutics (VKTX) and Amgen (AMGN) — are expecting to post the results of their next-gen weight loss…